Enanta Pharmaceuticals (ENTA) EPS (Basic) (2012 - 2026)
Enanta Pharmaceuticals' (ENTA) quarterly EPS (Basic) came in at -$0.45 in Q1 2026, up 57.49% YoY from -$0.29 in Q1 2025, and down 8.56% on a QoQ basis from -$0.42 in Q4 2025.
Enanta Pharmaceuticals (ENTA) EPS (Basic) (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 15 years of EPS (Basic) data on file, last reported at -$0.45 in Q1 2026.
- Quarterly EPS (Basic) rose 57.49% year-over-year to -$0.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.13 (up 52.72% YoY) and the FY2025 annual result came in at -$3838.1, up 30.03% from the prior year.
- EPS (Basic) eased to -$0.45 in Q1 2026, from -$0.42 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.42 in Q4 2025 to a low of -$1362.3 in Q3 2024.
- A 5-year average of -$279.64 and a median of -$1.53 in 2022 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 68.5% in 2022, down 28.71% in 2022.
- Tracing ENTA's EPS (Basic) over 5 years: stood at -$1.39 in 2022, then slipped by 13.77% to -$1.58 in 2023, then soared by 33.75% to -$1.05 in 2024, then surged by 60.43% to -$0.42 in 2025, then decreased by 8.56% to -$0.45 in 2026.
- The last three EPS (Basic) figures came in at -$0.45 (Q1 2026), -$0.42 (Q4 2025), and -$876.45 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - | -0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.67 |
| Mar 31, 2026 | -0.45 |
| Dec 31, 2025 | -0.42 |
| Sep 30, 2025 | -876.45 |
| Jun 30, 2025 | -0.85 |
| Mar 31, 2025 | -1.06 |
| Dec 31, 2024 | -1.05 |
| Sep 30, 2024 | -1,362.34 |
| Jun 30, 2024 | -1.07 |
| Mar 31, 2024 | -1.47 |
| Dec 31, 2023 | -1.58 |
| Sep 30, 2023 | -1,220.13 |
| Jun 30, 2023 | -1.86 |
| Mar 31, 2023 | -1.79 |
| Dec 31, 2022 | -1.39 |
| Sep 30, 2022 | -1,278.84 |
| Jun 30, 2022 | -1.53 |
| Mar 31, 2022 | -1.63 |
| Dec 31, 2021 | -1.48 |
| Sep 30, 2021 | -4,060.43 |